Clean cut cigarettes: fictitious launch foreshadows actual tobacco industry strategy.
A fictitious cigarette brand, "launched" at the 11th World Conference on Tobacco or Health, appears to have been adopted by Philip Morris.
Biomedical subjects
Publications and source records attributed to Joseph G Gitchell.
A fictitious cigarette brand, "launched" at the 11th World Conference on Tobacco or Health, appears to have been adopted by Philip Morris.
Over the past 20 years, medicinal nicotine has been used to aid smoking cessation, and has led to a significant increase in the number of smokers who successfully quit. This review describes currently available medicinal nicotine products, which include nicotine patch, gum, lozenge, nasal spray, inhaler and sublingual tablet, including their pharmacokinetics and recommended dosing. New developments in nicotine delivery that could further increase cessation rates include high-dose patches, rapid release gum, combined patch and acute forms, and several novel channels for nicotine delivery, such as nicotine drink, straw, lollipop and a pulmonary inhaler. New applications of existing and novel medicinal nicotine products may include relapse prevention, nicotine maintenance, temporary withdrawal management, reduced smoking and gradual quitting.